The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Anhui Tianlun Infertility Specialist Hospital, Hefei, China.
Cell Transplant. 2022 Jan-Dec;31:9636897221084354. doi: 10.1177/09636897221084354.
Mesenchymal stem cells derived from umbilical cord Wharton's Jelly (WJ-MSCs) are emerging as promising therapeutics for a variety of diseases due to their ability of regeneration and immunomodulation, and their non-tumorigenic and non-immunogenic properties. Although multiple protocols have been developed for WJ-MSC isolation, insufficient cell numbers, heterogeneous cell population, and variations in procedures between different laboratories impede further clinical applications. Here, we compared six widely used WJ-MSC isolation methods regarding cell morphology, yield, purity, proliferation rate, and differentiation potential. Based on these analyses, we identified that the inefficiency of the extracellular matrix digestion results in low cell yield. Thus, we developed a new method called "Mince-Soak-Digest (MSD)" to isolate MSCs from WJ by incorporating a soaking step to facilitate the digestion of the extracellular matrix and release of the cells. Our newly developed method generates significantly higher cell yield (4- to 10-fold higher) than six widely used methods that we tested with high purity and consistency. Importantly, by transplantation of WJ-MSCs to the rat uterus, we repair the endometrial injury and restore the fertility of the rats. In conclusion, our results provide a robust and highly efficient approach for the isolation of WJ-MSCs to restore injured tissue. The higher efficiency of MSD assures the abundance of WJ-MSCs for clinical applications. Furthermore, the reliability of MSD contributes to the standardization of WJ-MSC isolation, which eliminates the discrepancies due to isolation procedures, thus facilitating the evaluation of the efficacy of WJ-MSCs across various human clinical applications.
脐带华通氏胶间充质干细胞(WJ-MSCs)由于其再生和免疫调节能力,以及非致瘤性和非免疫原性特性,正在成为多种疾病有前途的治疗方法。尽管已经开发出多种 WJ-MSC 分离方案,但细胞数量不足、细胞群体异质性以及不同实验室之间程序的差异阻碍了进一步的临床应用。在这里,我们比较了六种广泛使用的 WJ-MSC 分离方法,比较了细胞形态、产量、纯度、增殖率和分化潜能。基于这些分析,我们发现细胞外基质消化效率低下导致细胞产量低。因此,我们开发了一种新的方法,称为“切碎-浸泡-消化(MSD)”,通过加入浸泡步骤来分离 WJ 中的 MSC,从而促进细胞外基质的消化和细胞的释放。与我们测试的六种广泛使用的方法相比,我们新开发的方法产生的细胞产量显著更高(高 4 到 10 倍),具有高纯度和一致性。重要的是,通过将 WJ-MSCs 移植到大鼠子宫中,我们修复了子宫内膜损伤并恢复了大鼠的生育能力。总之,我们的结果提供了一种强大且高效的分离 WJ-MSCs 以修复受损组织的方法。MSD 的高效率保证了 WJ-MSCs 用于临床应用的丰富程度。此外,MSD 的可靠性有助于 WJ-MSC 分离的标准化,消除了由于分离程序导致的差异,从而便于评估 WJ-MSCs 在各种人类临床应用中的疗效。